NFAT proteins: emerging roles in cancer progression (original) (raw)

• Crabtree, G. R. & Olson, E. N. NFAT signaling: choreographing the social lives of cells. Cell 109 S67–79 (2002).
  CAS PubMed Google Scholar
• Hogan, P. G., Chen, L., Nardone, J. & Rao, A. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 17, 2205–2232 (2003).
  CAS PubMed Google Scholar
• Shaw, J. P. et al. Identification of a putative regulator of early T cell activation genes. Science 241, 202–205 (1988).
  CAS PubMed Google Scholar
• Jauliac, S. et al. The role of NFAT transcription factors in integrin-mediated carcinoma invasion. Nature Cell Biol. 4, 540–544 (2002). This is the first study to demonstrate that NFATs are pro-migration and invasion transcription factors in breast cancer.
  CAS PubMed Google Scholar
• Medyouf, H. et al. Targeting calcineurin activation as a therapeutic strategy for T-cell acute lymphoblastic leukemia. Nature Med. 13, 736–741 (2007).
  CAS PubMed Google Scholar
• Ryeom, S. et al. Targeted deletion of the calcineurin inhibitor DSCR1 suppresses tumor growth. Cancer Cell 13, 420–431 (2008).
  CAS PubMed Google Scholar
• Imamura, R. et al. Carboxyl-terminal 15-amino acid sequence of NFATx1 is possibly created by tissue-specific splicing and is essential for transactivation activity in T cells. J. Immunol. 161, 3455–3463 (1998).
  CAS PubMed Google Scholar
• Chuvpilo, S. et al. Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes. J. Immunol. 162, 7294–7301 (1999).
  CAS PubMed Google Scholar
• Chuvpilo, S. et al. Alternative polyadenylation events contribute to the induction of NF-ATc in effector T cells. Immunity 10, 261–269 (1999).
  CAS PubMed Google Scholar
• Chen, L., Glover, J. N., Hogan, P. G., Rao, A. & Harrison, S. C. Structure of the DNA-binding domains from NFAT, Fos and Jun bound specifically to DNA. Nature 392, 42–48 (1998).
  CAS PubMed Google Scholar
• Lopez-Rodriguez, C., Aramburu, J., Rakeman, A. S. & Rao, A. NFAT5, a constitutively nuclear NFAT protein that does not cooperate with Fos and Jun. Proc. Natl Acad. Sci. USA 96, 7214–7219 (1999).
  CAS PubMed PubMed Central Google Scholar
• Miyakawa, H., Woo, S. K., Dahl, S. C., Handler, J. S. & Kwon, H. M. Tonicity-responsive enhancer binding protein, a rel-like protein that stimulates transcription in response to hypertonicity. Proc. Natl Acad. Sci. USA 96, 2538–2542 (1999).
  CAS PubMed PubMed Central Google Scholar
• Yang, T. T., Xiong, Q., Graef, I. A., Crabtree, G. R. & Chow, C. W. Recruitment of the extracellular signal-regulated kinase/ribosomal S6 kinase signaling pathway to the NFATc4 transcription activation complex. Mol. Cell. Biol. 25, 907–920 (2005).
  CAS PubMed PubMed Central Google Scholar
• Giffin, M. J. et al. Structure of NFAT1 bound as a dimer to the HIV-1 LTR κB element. Nature Struct. Biol. 10, 800–806 (2003).
  CAS PubMed Google Scholar
• Jain, J., McCaffrey, P. G., Valge-Archer, V. E. & Rao, A. Nuclear factor of activated T cells contains Fos and Jun. Nature 356, 801–804 (1992).
  CAS PubMed Google Scholar
• Wu, Y. et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126, 375–387 (2006).
  Article CAS PubMed Google Scholar
• Macian, F. NFAT proteins: key regulators of T-cell development and function. Nature Rev. Immunol. 5, 472–484 (2005).
  CAS Google Scholar
• Penna, A. et al. The CRAC channel consists of a tetramer formed by Stim-induced dimerization of Orai dimers. Nature 456, 116–120 (2008).
  CAS PubMed PubMed Central Google Scholar
• Oh-Hora, M. et al. Dual functions for the endoplasmic reticulum calcium sensors STIM1 and STIM2 in T cell activation and tolerance. Nature Immunol. 9, 432–443 (2008).
  CAS Google Scholar
• Prakriya, M. et al. Orai1 is an essential pore subunit of the CRAC channel. Nature 443, 230–233 (2006).
  CAS PubMed Google Scholar
• Feske, S. et al. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 441, 179–185 (2006).
  CAS PubMed Google Scholar
• Yeromin, A. V. et al. Molecular identification of the CRAC channel by altered ion selectivity in a mutant of Orai. Nature 443, 226–229 (2006).
  CAS PubMed PubMed Central Google Scholar
• Cahalan, M. D. STIMulating store-operated Ca2+ entry. Nature Cell Biol. 11, 669–677 (2009).
  CAS PubMed Google Scholar
• Gwack, Y., Feske, S., Srikanth, S., Hogan, P. G. & Rao, A. Signalling to transcription: store-operated Ca2+ entry and NFAT activation in lymphocytes. Cell Calcium 42, 145–156 (2007).
  CAS PubMed Google Scholar
• Okamura, H. et al. Concerted dephosphorylation of the transcription factor NFAT1 induces a conformational switch that regulates transcriptional activity. Mol. Cell 6, 539–550 (2000).
  CAS PubMed Google Scholar
• Zhu, J. & McKeon, F. NF-AT activation requires suppression of Crm1-dependent export by calcineurin. Nature 398, 256–260 (1999).
  CAS PubMed Google Scholar
• Beals, C. R., Sheridan, C. M., Turck, C. W., Gardner, P. & Crabtree, G. R. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science 275, 1930–1934 (1997). The first study demonstrating that GSK3 is a nuclear export kinase for NFAT.
  CAS PubMed Google Scholar
• Neal, J. W. & Clipstone, N. A. Glycogen synthase kinase-3 inhibits the DNA binding activity of NFATc. J. Biol. Chem. 276, 3666–3673 (2000).
  PubMed Google Scholar
• Engelman, J. A. Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nature Rev. Cancer 9, 550–562 (2009).
  CAS Google Scholar
• Okamura, H. et al. A conserved docking motif for CK1 binding controls the nuclear localizationof NFAT1. Mol. Cell. Biol. 24, 4184–4195 (2004).
  CAS PubMed PubMed Central Google Scholar
• Zhu, J. et al. Intramolecular masking of nuclear import signal on NF-AT4 by casein kinase I and MEKK1. Cell 93, 851–861 (1998).
  CAS PubMed Google Scholar
• Chow, C. W., Dong, C., Flavell, R. A. & Davis, R. J. c-Jun NH2-terminal kinase inhibits targeting of the protein phosphatase calcineurin to NFATc1. Mol. Cell. Biol. 20, 5227–5234 (2000).
  CAS PubMed PubMed Central Google Scholar
• Yang, T. T., Xiong, Q., Enslen, H., Davis, R. J. & Chow, C. W. Phosphorylation of NFATc4 by p38 mitogen-activated protein kinases. Mol. Cell. Biol. 22, 3892–3904 (2002).
  CAS PubMed PubMed Central Google Scholar
• Gwack, Y. et al. A genome-wide Drosophila RNAi screen identifies DYRK-family kinases as regulators of NFAT. Nature 441, 646–650 (2006).
  CAS PubMed Google Scholar
• Arron, J. R. et al. NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature 441, 595–600 (2006). References 34 and 35 define DYRKs as the long-sought-after export and maintenance kinases for NFATs.
  CAS PubMed Google Scholar
• Nayak, A. et al. Sumoylation of the transcription factor NFATc1 leads to its subnuclear relocalization and interleukin-2 repression by histone deacetylase. J. Biol. Chem. 284, 10935–10946 (2009).
  CAS PubMed PubMed Central Google Scholar
• Terui, Y., Saad, N., Jia, S., McKeon, F. & Yuan, J. Dual role of sumoylation in the nuclear localization and transcriptional activation of NFAT1. J. Biol. Chem. 279, 28257–28265 (2004).
  CAS PubMed Google Scholar
• Yoeli-Lerner, M. et al. Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. Mol. Cell 20, 539–550 (2005). This paper shows that, in breast cancer cells, NFAT1 is ubiquitylated by the E3 ligase MDM2, which targets it for degradation.
  CAS PubMed Google Scholar
• Yoeli-Lerner, M., Chin, Y. R., Hansen, C. K. & Toker, A. Akt/protein kinase B and glycogen synthase kinase-3β signaling pathway regulates cell migration through the NFAT1 transcription factor. Mol. Cancer Res. 7, 425–432 (2009).
  CAS PubMed PubMed Central Google Scholar
• Neal, J. W. & Clipstone, N. A. A constitutively active NFATc1 mutant induces a transformed phenotype in 3T3-L1 fibroblasts. J. Biol. Chem. 278, 17246–17254 (2003).
  CAS PubMed Google Scholar
• Buchholz, M. et al. Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathway. EMBO J. 25, 3714–3724 (2006).
  CAS PubMed PubMed Central Google Scholar
• Robbs, B. K., Cruz, A. L., Werneck, M. B., Mognol, G. P. & Viola, J. P. Dual roles for NFAT transcription factor genes as oncogenes and tumor suppressors. Mol. Cell. Biol. 28, 7168–7181 (2008). This paper shows that, in fibroblasts, distinct NFAT isoforms have non-overlapping roles as oncogenes and tumour suppressors, as revealed in both in vitro studies and mouse models.
  CAS PubMed PubMed Central Google Scholar
• Marafioti, T. et al. The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomas. Br. J. Haematol. 128, 333–342 (2005).
  CAS PubMed Google Scholar
• Pham, L. V., Tamayo, A. T., Yoshimura, L. C., Lin-Lee, Y. C. & Ford, R. J. Constitutive NF-κB and NFAT activation in aggressive B-cell lymphomas synergistically activates the CD154 gene and maintains lymphoma cell survival. Blood 106, 3940–3947 (2005).
  CAS PubMed PubMed Central Google Scholar
• Horsley, V., Aliprantis, A. O., Polak, L., Glimcher, L. H. & Fuchs, E. NFATc1 balances quiescence and proliferation of skin stem cells. Cell 132, 299–310 (2008).
  CAS PubMed PubMed Central Google Scholar
• Mani, S. A. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704–715 (2008).
  CAS PubMed PubMed Central Google Scholar
• Thiery, J. P. Epithelial-mesenchymal transitions in tumour progression. Nature Rev. Cancer 2, 442–454 (2002).
  CAS Google Scholar
• Jonsson, M., Dejmek, J., Bendahl, P. O. & Andersson, T. Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas. Cancer Res. 62, 409–416 (2002).
  CAS PubMed Google Scholar
• Dejmek, J., Safholm, A., Kamp Nielsen, C., Andersson, T. & Leandersson, K. Wnt-5a/Ca2+-induced NFAT activity is counteracted by Wnt-5a/Yes-Cdc42-casein kinase 1α signaling in human mammary epithelial cells. Mol. Cell. Biol. 26, 6024–6036 (2006).
  CAS PubMed PubMed Central Google Scholar
• Rabinovitz, I. & Mercurio, A. M. The integrin α6β4 functions in carcinoma cell migration on laminin-1 by mediating the formation and stabilization of actin- containing motility structures. J. Cell Biol. 139, 1873–1884 (1997).
  CAS PubMed PubMed Central Google Scholar
• Mercurio, A. M. & Rabinovitz, I. Towards a mechanistic understanding of tumor invasion-lessons from the α6β4 integrin. Semin. Cancer Biol. 11, 129–141 (2001).
  CAS PubMed Google Scholar
• Yiu, G. K. & Toker, A. NFAT induces breast cancer cell invasion by promoting the induction of cyclooxygenase-2. J. Biol. Chem. 281, 12210–12217 (2006).
  CAS PubMed Google Scholar
• Chen, M. & O'Connor, K., L., Integrin α6β4 promotes expression of autotaxin/ENPP2 autocrine motility factor in breast carcinoma cells. Oncogene 24, 5125–5130 (2005).
  CAS PubMed Google Scholar
• Stracke, M. L. et al. Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. J. Biol. Chem. 267, 2524–2529 (1992).
  CAS PubMed Google Scholar
• Yang, S. Y. et al. Expression of autotaxin (NPP-2) is closely linked to invasiveness of breast cancer cells. Clin. Exp. Metastasis 19, 603–608 (2002).
  CAS PubMed Google Scholar
• Liu, S. et al. Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases. Cancer Cell 15, 539–550 (2009). A recent study that highlights the potent metastatic activity of autotaxin and its product LPA in breast cancer progression.
  CAS PubMed PubMed Central Google Scholar
• Zhang, H. et al. Dual activity lysophosphatidic acid receptor pan-antagonist/autotaxin inhibitor reduces breast cancer cell migration In vitro and causes tumor regression In vivo. Cancer Res. 69, 5441–5449 (2009).
  CAS PubMed PubMed Central Google Scholar
• Mott, J. D. & Werb, Z. Regulation of matrix biology by matrix metalloproteinases. Curr. Opin. Cell Biol. 16, 558–564 (2004).
  CAS PubMed PubMed Central Google Scholar
• Nagy, J. A., Dvorak, A. M. & Dvorak, H. F. VEGF-A and the induction of pathological angiogenesis. Annu. Rev. Pathol. 2, 251–275 (2007).
  CAS PubMed Google Scholar
• Dvorak, H. F. Discovery of vascular permeability factor (VPF). Exp. Cell Res. 312, 522–526 (2006).
  CAS PubMed Google Scholar
• Ferrara, N., Gerber, H. P. & LeCouter, J. The biology of VEGF and its receptors. Nature Med. 9, 669–676 (2003).
  CAS PubMed Google Scholar
• Hernandez, G. L. et al. Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2. J. Exp. Med. 193, 607–620 (2001).
  CAS PubMed PubMed Central Google Scholar
• Gupta, G. P. et al. Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature 446, 765–770 (2007).
  CAS PubMed Google Scholar
• Bos, P. D. et al. Genes that mediate breast cancer metastasis to the brain. Nature 459, 1005–1009 (2009).
  CAS PubMed PubMed Central Google Scholar
• Armesilla, A. L. et al. Vascular endothelial growth factor activates nuclear factor of activated T cells in human endothelial cells: a role for tissue factor gene expression. Mol. Cell. Biol. 19, 2032–2043 (1999).
  CAS PubMed PubMed Central Google Scholar
• Cockerill, G. W. et al. Regulation of granulocyte-macrophage colony-stimulating factor and E-selectin expression in endothelial cells by cyclosporin A and the T-cell transcription factor NFAT. Blood 86, 2689–2698 (1995).
  CAS PubMed Google Scholar
• Jinnin, M. et al. Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma. Nature Med. 14, 1236–1246 (2008). NFAT activation is shown to lead to expression of VEGFRs and downstream signalling in haemangiomas, which are highly vascularized benign lesions typically seen in children.
  CAS PubMed Google Scholar
• Hasle, H., Clemmensen, I. H. & Mikkelsen, M. Risks of leukaemia and solid tumours in individuals with Down's syndrome. Lancet 355, 165–169 (2000).
  CAS PubMed Google Scholar
• Baek, K. H. et al. Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature 459, 1126–1130 (2009). References 69 and 6 reveal that DSCR1, a suppressor of calcineurin activity in endothelial cells, can function as a suppressor of tumour growth by attenuating NFAT activity and VEGFA induction, as observed in patients with Down's syndrome who have increased expression of DSCR1.
  CAS PubMed PubMed Central Google Scholar
• Qin, L. et al. Down syndrome candidate region 1 isoform 1 mediates angiogenesis through the calcineurin-NFAT pathway. Mol. Cancer Res. 4, 811–820 (2006).
  CAS PubMed Google Scholar
• Stacker, S. A., Achen, M. G., Jussila, L., Baldwin, M. E. & Alitalo, K. Lymphangiogenesis and cancer metastasis. Nature Rev. Cancer 2, 573–583 (2002).
  CAS Google Scholar
• Skobe, M. et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nature Med. 7, 192–198 (2001).
  CAS PubMed Google Scholar
• Karpanen, T. et al. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res. 61, 1786–1790 (2001).
  CAS PubMed Google Scholar
• Kulkarni, R. M., Greenberg, J. M. & Akeson, A. L. NFATc1 regulates lymphatic endothelial development. Mech. Dev. 126, 350–365 (2009).
  CAS PubMed PubMed Central Google Scholar
• Norrmen, C. et al. FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1. J. Cell Biol. 185, 439–457 (2009).
  CAS PubMed PubMed Central Google Scholar
• Campbell, J. J. & Butcher, E. C. Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr. Opin. Immunol. 12, 336–341 (2000).
  CAS PubMed Google Scholar
• Butcher, E. C., Williams, M., Youngman, K., Rott, L. & Briskin, M. Lymphocyte trafficking and regional immunity. Adv. Immunol. 72, 209–253 (1999).
  CAS PubMed Google Scholar
• Muller, A. et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 410, 50–56 (2001). Chemokines and chemokine receptors are shown to be highly upregulated and functional for metastatic dissemination of breast cancer cells in this paper.
  CAS PubMed Google Scholar
• Karnoub, A. E. & Weinberg, R. A. Chemokine networks and breast cancer metastasis. Breast Dis. 26, 75–85 (2006).
  CAS PubMed Google Scholar
• Karnoub, A. E. et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449, 557–563 (2007).
  CAS PubMed Google Scholar
• Wyckoff, J. et al. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res. 64, 7022–7029 (2004).
  CAS PubMed Google Scholar
• Kaufman, D. B. et al. Immunosuppression: practice and trends. Am. J. Transplant 4 Suppl. 9, 38–53 (2004).
  PubMed Google Scholar
• Martinez-Martinez, S. & Redondo, J. M. Inhibitors of the calcineurin/NFAT pathway. Curr. Med. Chem. 11, 997–1007 (2004).
  CAS PubMed Google Scholar
• Matsuda, S. & Koyasu, S. Mechanisms of action of cyclosporine. Immunopharmacology 47, 119–125 (2000).
  CAS PubMed Google Scholar
• Liu, J. et al. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66, 807–815 (1991).
  CAS PubMed Google Scholar
• Kiani, A., Rao, A. & Aramburu, J. Manipulating immune responses with immunosuppressive agents that target NFAT. Immunity 12, 359–372 (2000).
  CAS PubMed Google Scholar
• Rezzani, R. Cyclosporine A and adverse effects on organs: histochemical studies. Prog. Histochem. Cytochem. 39, 85–128 (2004).
  CAS PubMed Google Scholar
• Dantal, J. & Soulillou, J. P. Immunosuppressive drugs and the risk of cancer after organ transplantation. N. Engl. J. Med. 352, 1371–1373 (2005).
  CAS PubMed Google Scholar
• Aramburu, J. et al. Selective inhibition of NFAT activation by a peptide spanning the calcineurin targeting site of NFAT. Mol. Cell 1, 627–637 (1998).
  CAS PubMed Google Scholar
• Aramburu, J. et al. Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science 285, 2129–2133 (1999).
  CAS PubMed Google Scholar
• Noguchi, H. et al. A new cell-permeable peptide allows successful allogeneic islet transplantation in mice. Nature Med. 10, 305–309 (2004).
  CAS PubMed Google Scholar
• Karanam, B. V. et al. Disposition of L-732531, a potent immunosuppressant, in rats and baboons. Drug Metab. Dispos. 26, 949–957 (1998).
  CAS PubMed Google Scholar
• Abel, M. D. et al. ISATX247: a novel calcineurin inhibitor. J. Heart Lung Transplant 20, 161 (2001).
  PubMed Google Scholar
• Brundage, R. A., Fogarty, K. E., Tuft, R. A. & Fay, F. S. Calcium gradients underlying polarization and chemotaxis of eosinophils. Science 254, 703–706 (1991).
  CAS PubMed Google Scholar
• Evans, J. H. & Falke, J. J. Ca2+ influx is an essential component of the positive-feedback loop that maintains leading-edge structure and activity in macrophages. Proc. Natl Acad. Sci. USA 104, 16176–16181 (2007).
  CAS PubMed PubMed Central Google Scholar
• Wei, C. et al. Calcium flickers steer cell migration. Nature 457, 901–905 (2009).
  CAS PubMed Google Scholar
• Yang, S., Zhang, J. J. & Huang, X. Y. Orai1 and STIM1 are critical for breast tumor cell migration and metastasis. Cancer Cell 15, 124–134 (2009). This paper reveals that the store-operated calcium channels STIM1 and ORAI1 promote calcium signals that are required for cell migration.
  CAS PubMed Google Scholar
• Szado, T. et al. Phosphorylation of inositol 1,4,5-trisphosphate receptors by protein kinase B/Akt inhibits Ca2+ release and apoptosis. Proc. Natl Acad. Sci. USA 105, 2427–2432 (2008).
  CAS PubMed PubMed Central Google Scholar
• Masuda, E. S., Imamura, R., Amasaki, Y., Arai, K. & Arai, N. Signalling into the T-cell nucleus: NFAT regulation. Cell Signal 10, 599–611 (1998).
  CAS PubMed Google Scholar
• Horsley, V. & Pavlath, G. K. NFAT: ubiquitous regulator of cell differentiation and adaptation. J. Cell Biol. 156, 771–774 (2002).
  CAS PubMed PubMed Central Google Scholar
• Amasaki, Y. et al. A constitutively nuclear form of NFATx shows efficient transactivation activity and induces differentiation of CD4+CD8+ T cells. J. Biol. Chem. 277, 25640–25648 (2002).
  CAS PubMed Google Scholar
• Ranger, A. M., Oukka, M., Rengarajan, J. & Glimcher, L. H. Inhibitory function of two NFAT family members in lymphoid homeostasis and Th2 development. Immunity 9, 627–635 (1998).
  CAS PubMed Google Scholar
• Graef, I. A., Chen, F., Chen, L., Kuo, A. & Crabtree, G. R. Signals transduced by Ca2+/calcineurin and NFATc3/c4 pattern the developing vasculature. Cell 105, 863–875 (2001).
  CAS PubMed Google Scholar
• Rengarajan, J., Tang, B. & Glimcher, L. H. NFATc2 and NFATc3 regulate TH2 differentiation and modulate TCR-responsiveness of naive TH cells. Nature Immunol. 3, 48–54 (2002).
  CAS Google Scholar